- Home
- SANG vs ACHV Comparison
SANG vs ACHV Comparison
Compare SANG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANG | ACHV |
|---|---|---|
| Founded | 1984 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.0M | 239.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SANG | ACHV |
|---|---|---|
| Price | $5.04 | $4.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 4.6K | ★ 608.4K |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $227,360,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.08 | $1.84 |
| 52 Week High | $7.99 | $5.78 |
Technical Indicators
Market Signals| Indicator | SANG | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 42.76 |
| Support Level | $5.03 | $4.57 |
| Resistance Level | $5.42 | $4.86 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 7.41 | 0.61 |
Price Performance
Historical ComparisonAbout SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.